Kymera Therapeutics recently reported progress across its immunology pipeline, including advancing IRAK4, STAT6, TYK2, and KT-621 programs, while also disclosing CEO share sales and responding to ...
WATERTOWN, Mass., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines ...
Hosted on MSN
Kymera - The Chevy 4X4 monster truck
TRANSFORMING a standard truck into an off road monster has been a passion project for one man and his team of genius engineers. Gregg Higgs is owner of Fab Fours, a car accessory manufacturer that has ...
Hosted on MSN
Wolfe Research downgrades Kymera Therapeutics (KYMR)
Fintel reports that on January 6, 2026, Wolfe Research downgraded their outlook for Kymera Therapeutics (NasdaqGM:KYMR) from Outperform to Peer Perform. Analyst Price Forecast Suggests 54.37% Upside ...
Investing.com - Wolfe Research downgraded Kymera Therapeutics (NASDAQ:KYMR) from Outperform to Peerperform on Tuesday. The stock currently trades at $72.41, having delivered an impressive 81.48% ...
Tom Bowen is a senior editor who loves adventure games and RPGs. He's been playing video games for several decades now and writing about them professionally since 2020. Although he dabbles in news and ...
In a report released yesterday, Jeet Mukherjee from BTIG maintained a Buy rating on Kymera Therapeutics, with a price target of $138.00. The company’s shares closed yesterday at $73.46. According to ...
NW, W (15 second or under). The state park coalition has built a pay lot right in front of the point, but free parking is available just outside the gates along the highway. The wave is easy to find, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results